Baird Maintains Outperform on Bio-Techne, Raises Price Target to $82
Portfolio Pulse from Benzinga Newsdesk
Baird analyst Catherine Schulte maintains an Outperform rating on Bio-Techne (NASDAQ:TECH) and raises the price target from $81 to $82.
August 08, 2024 | 12:01 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Baird analyst Catherine Schulte maintains an Outperform rating on Bio-Techne and raises the price target from $81 to $82.
The Outperform rating and increased price target from a reputable analyst can boost investor confidence and potentially drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100